Literature DB >> 23449788

Variation of HIV-1 mutation spectra among cell types.

Colleen M Holtz1, Louis M Mansky.   

Abstract

The high rates of mutation, recombination, and replication drive HIV-1 diversity. In this study, we investigated how cell type affects viral mutation rate and mutation spectra. In studying four different cell types, no differences in mutation rate were observed, but intriguingly cell type differences impacted HIV-1 mutation spectra. This is the first description of significant differences in HIV-1 mutation spectra observed in different cell types in the absence of changes in the viral mutation rate.

Entities:  

Mesh:

Year:  2013        PMID: 23449788      PMCID: PMC3624292          DOI: 10.1128/JVI.03576-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  DNA deamination mediates innate immunity to retroviral infection.

Authors:  Reuben S Harris; Kate N Bishop; Ann M Sheehy; Heather M Craig; Svend K Petersen-Mahrt; Ian N Watt; Michael S Neuberger; Michael H Malim
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

2.  Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis.

Authors:  Patrick K O'Neil; Guoli Sun; Hong Yu; Yacov Ron; Joseph P Dougherty; Bradley D Preston
Journal:  J Biol Chem       Date:  2002-07-31       Impact factor: 5.157

3.  Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.

Authors:  Qin Yu; Renate König; Satish Pillai; Kristopher Chiles; Mary Kearney; Sarah Palmer; Douglas Richman; John M Coffin; Nathaniel R Landau
Journal:  Nat Struct Mol Biol       Date:  2004-04-18       Impact factor: 15.369

4.  APOBEC3G contributes to HIV-1 variation through sublethal mutagenesis.

Authors:  Holly A Sadler; Mark D Stenglein; Reuben S Harris; Louis M Mansky
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

5.  Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1.

Authors:  Judd F Hultquist; Joy A Lengyel; Eric W Refsland; Rebecca S LaRue; Lela Lackey; William L Brown; Reuben S Harris
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

Review 6.  The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review.

Authors:  Catherine A Hankins; Mark R Dybul
Journal:  Curr Opin HIV AIDS       Date:  2013-01       Impact factor: 4.283

7.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

8.  Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.

Authors:  Eric W Refsland; Mark D Stenglein; Keisuke Shindo; John S Albin; William L Brown; Reuben S Harris
Journal:  Nucleic Acids Res       Date:  2010-03-22       Impact factor: 16.971

9.  Back to the future: revisiting HIV-1 lethal mutagenesis.

Authors:  Michael J Dapp; Steven E Patterson; Louis M Mansky
Journal:  Trends Microbiol       Date:  2012-11-27       Impact factor: 17.079

10.  Target cell-mediated editing of HIV-1 cDNA by APOBEC3 proteins in human macrophages.

Authors:  Fransje A Koning; Caroline Goujon; Hélène Bauby; Michael H Malim
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

View more
  19 in total

1.  Single-Strand Consensus Sequencing Reveals that HIV Type but not Subtype Significantly Impacts Viral Mutation Frequencies and Spectra.

Authors:  Jonathan M O Rawson; Daryl M Gohl; Sean R Landman; Megan E Roth; Morgan E Meissner; Tara S Peterson; James S Hodges; Kenneth B Beckman; Louis M Mansky
Journal:  J Mol Biol       Date:  2017-05-11       Impact factor: 5.469

Review 2.  The complexity of HIV persistence and pathogenesis in the lung under antiretroviral therapy: challenges beyond AIDS.

Authors:  Sharilyn Almodovar
Journal:  Viral Immunol       Date:  2014-05-05       Impact factor: 2.257

3.  Differential Activity of APOBEC3F, APOBEC3G, and APOBEC3H in the Restriction of HIV-2.

Authors:  Morgan E Meissner; Nora A Willkomm; Jamie Lucas; William G Arndt; Sarah F Aitken; Emily J Julik; Sunanda Baliga; Louis M Mansky
Journal:  J Mol Biol       Date:  2021-11-10       Impact factor: 5.469

4.  Deamination hotspots among APOBEC3 family members are defined by both target site sequence context and ssDNA secondary structure.

Authors:  Yumeng Z McDaniel; Dake Wang; Robin P Love; Madison B Adolph; Nazanin Mohammadzadeh; Linda Chelico; Louis M Mansky
Journal:  Nucleic Acids Res       Date:  2020-02-20       Impact factor: 16.971

5.  Blocking interaction of viral gp120 and CD4-expressing T cells by single-stranded DNA aptamers.

Authors:  Nianxi Zhao; Sung-nan Pei; Parag Parekh; Eric Salazar; Youli Zu
Journal:  Int J Biochem Cell Biol       Date:  2014-03-22       Impact factor: 5.085

6.  Human immunodeficiency virus reverse transcriptase displays dramatically higher fidelity under physiological magnesium conditions in vitro.

Authors:  Vasudevan Achuthan; Brian J Keith; Bernard A Connolly; Jeffrey J DeStefano
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

7.  Extremely High Mutation Rate of HIV-1 In Vivo.

Authors:  José M Cuevas; Ron Geller; Raquel Garijo; José López-Aldeguer; Rafael Sanjuán
Journal:  PLoS Biol       Date:  2015-09-16       Impact factor: 8.029

8.  HIV-1 and HIV-2 exhibit similar mutation frequencies and spectra in the absence of G-to-A hypermutation.

Authors:  Jonathan M O Rawson; Sean R Landman; Cavan S Reilly; Louis M Mansky
Journal:  Retrovirology       Date:  2015-07-10       Impact factor: 4.602

9.  HIV-1 Tropism Determines Different Mutation Profiles in Proviral DNA.

Authors:  Sieberth Nascimento-Brito; Jean Paulo Zukurov; Juliana T Maricato; Angela C Volpini; Anna Christina M Salim; Flávio M G Araújo; Roney S Coimbra; Guilherme C Oliveira; Fernando Antoneli; Luiz Mário R Janini
Journal:  PLoS One       Date:  2015-09-28       Impact factor: 3.240

10.  Variation in RNA virus mutation rates across host cells.

Authors:  Marine Combe; Rafael Sanjuán
Journal:  PLoS Pathog       Date:  2014-01-23       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.